Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exova was a prominent global provider of laboratory testing, advising, and inspection services, with a specialized division dedicated to Health Sciences. The company provided critical analytical chemistry, microbiology, and stability testing services to the pharmaceutical, biopharmaceutical, and medical device sectors. Headquartered in Edinburgh, Exova operated a vast network of laboratories that supported drug development and ensured regulatory compliance for healthcare products. In 2017, the company was acquired by Element Materials Technology for approximately £620 million, leading to the integration of its services into Element's global platform. This acquisition significantly expanded Element's capabilities in the life sciences and materials testing markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Exova.